4//SEC Filing
CAUWENBERGH GEERT 4
Accession 0001209191-18-052657
CIK 0001533040other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 12:40 PM ET
Size
5.8 KB
Accession
0001209191-18-052657
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Common stock, $0.0001 par value
2018-09-28$1.17/sh+73,587$86,097→ 108,845 total
Holdings
- 450(indirect: By Spouse)
Common stock, $0.0001 par value
Footnotes (1)
- [F1]As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on September 28, 2018, the reporting person received a total of 73,587 shares of common stock from the Company in lieu of $86,096.16 of cash compensation that was payable on such date, which includes base salary and a portion of the reporting person's deferred annual bonus for 2017, which was paid on September 28, 2018.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001285648
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 12:40 PM ET
- Size
- 5.8 KB